MoneyWorks4Me

Aurobindo Pharma informs about analyst meet

18 Nov 2022 Evaluate
Aurobindo Pharma has informed that Yugandhar Puvvala, Chief Executive Officer of Eugia Pharma Specialities, a wholly owned subsidiary of the Company, will be interacting with officials of Abu Dhabi Investment Authority and Lion Global Investors, at corporate office today November 17, 2022, between 4.00 pm to 5.00 pm. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. 

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..